Danazol-induced Acute Pulmonary Fibrosis in a Patient with Idiopathic Thrombocytopenic Purpura: Could Anti Fibrosant Therapy be Useful?

René Agustín Flores-Franco, Víctor Salgado-Yáñez, Jesús Rivera-Olivas, Ernesto Ramos-Martı́nez
In: British Journal of Medicine and Medical Research · 2016 · vol. 16(12) , pp. 1–4 · doi:10.9734/bjmmr/2016/27778 · W2477882284
article OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-16 ⓘ

This case report describes a patient with idiopathic thrombocytopenic purpura who developed acute pulmonary fibrosis after treatment with danazol, raising the question of anti-fibrosant therapy efficacy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

International audience

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T11:26:16.120872+00:00
License: CC0 · commercial use OK